ABSTRACT: Stearoyl CoA desaturase (SCD) is responsible for converting SFA into MUFA and plays an important role in regulating the fatty acid composition of tissues. Although the number of SCD isoforms differs among species, SCD-1 is the predominant isoform expressed in the major lipogenic tissues of all species studied. The SCD-1 gene promoter region has been cloned for several species, including the human, mouse, pig, and recently, the cow. In this study, we cloned and partially characterized the ovine SCD promoter region. Sequence alignment showed a high degree of similarity with published bovine (94%) and porcine (92%) sequences. This included a highly conserved PUFA response region, which was also similar to that found in the human SCD and mouse SCD-1 promoters. Previous studies have indicated that there may be species differences in the regulation of SCD promoter activity by fatty acids. Using promoter-reporter gene (luciferase) constructs transfected into both HEK 293 and McA-RH7777 cells (kidney-and liver-derived cell lines, respectively), we showed the activity of the SCD promoter from 4 different species (mouse, human, pig, and sheep) to be reduced in a dose-dependent manner by addition of unsaturated fatty acids to the media, with linoleic acid being more potent than oleic acid after a 24-h treatment at 60 µM. This effect was dependent on the presence of the PUFA response region. In each of the species studied, the PUFA response region of the SCD promoter was shown to have an active sterol response element, which responded to treatment of cells with sterol or overexpression of the truncated active form of sterol regulatory element binding protein-1c. Thus, any species differences in previously reported regulation of SCD expression by fatty acids are not due to differences in promoter structure between species, but are more likely to depend on the cell type being studied or the relative concentrations and distribution of sterol regulatory element binding proteins or other transcription factors. ). It catalyzes the introduction of a cis double bond between carbons 9 and 10 of saturated fatty acyl-CoA substrates (Ntambi and Miyazaki, 2004) and has an important role in ruminants in converting trans-11 C18:1 vaccenic acid into cis-9, trans-11 C18:2 CLA (Bauman et al., 1999) . Stearoyl CoA desaturase activity is highly regulated and plays a major role in determining tissue fatty acid composition. Stearoyl CoA desaturase gene homologs have been identified in a range of species, many of which express multiple isoforms, with SCD-1 being the most abundant isoform in lipogenic tissues (Flowers et al., 2006) and common to most species. Activity and expression of SCD-1 have been reported to be regulated by fatty acids, although the responses appear to vary with the species. Diets rich in PUFA reduced SCD-1 mRNA in mice (Ntambi, 1992) , whereas linoleic acid reduced mouse SCD-1 mRNA (Landschulz et al., 1994) , rat SCD-1 mRNA 
INTRODUCTION
Stearoyl CoA desaturase (SCD, also called Δ 9 -desaturase) is an integral membrane-bound endoplasmic reticulum protein responsible for converting SFA to MUFA, primarily stearic acid (C18:0) into oleic acid (C18:1Δ 9 ). It catalyzes the introduction of a cis double bond between carbons 9 and 10 of saturated fatty acyl-CoA substrates (Ntambi and Miyazaki, 2004) and has an important role in ruminants in converting trans-11 C18:1 vaccenic acid into cis-9, trans-11 C18:2 CLA (Bauman et al., 1999) . Stearoyl CoA desaturase activity is highly regulated and plays a major role in determining tissue fatty acid composition. Stearoyl CoA desaturase gene homologs have been identified in a range of species, many of which express multiple isoforms, with SCD-1 being the most abundant isoform in lipogenic tissues (Flowers et al., 2006) and common to most species. Activity and expression of SCD-1 have been reported to be regulated by fatty acids, although the responses appear to vary with the species. Diets rich in PUFA reduced SCD-1 mRNA in mice (Ntambi, 1992) , whereas linoleic acid reduced mouse SCD-1 mRNA (Landschulz et al., 1994) , rat SCD-1 mRNA (Landschulz et al., 1994) , and human SCD promoter activity (Zhang et al., 2001) , but had no effect on bovine SCD promoter activity (Keating et al., 2006) . Likewise, oleic acid reduced rat SCD-1 mRNA (Landschulz et al., 1994) and bovine SCD promoter activity (Keating et al., 2006) , but had no effect on human SCD mRNA or protein (Bené et al., 2001) , and increasing dietary oleic acid had little effect in mice (Landschulz et al., 1994) . A PUFA response region (PUFA-RR), containing sterol response element (SRE) and transcription factor nuclear factor-Y binding sites, is believed important in the regulation of mouse SCD-1 promoter activity by fatty acids (Waters et al., 1997) . The present study isolated the ovine SCD promoter and investigated whether sequence differences at this promoter region might be responsible for any apparent species differences in SCD-1 response to fatty acids.
MATERIALS AND METHODS
Porcine and ovine blood samples for isolation of genomic DNA were obtained at slaughter with the approval of the University of Nottingham Ethics Committee. All other sequence data were obtained from an existing database (GenBank via the National Center for Biotechnology Information).
Bioinformatic Analyses
Published sequences for the SCD promoter regions from the different species (human, mouse, cow, and pig) were obtained and Basic Local Alignment Search Tool searches and sequence alignments (ClustalW) performed via the European Molecular Biology Laboratory database (http://www.ebi.ac.uk). Potential transcription factor binding sites were predicted using MatInspector (http://www.genomatix.de).
Generation of Porcine and Ovine SCD Promoter Reporter Constructs
Genomic DNA was isolated from porcine and ovine blood using the Wizard Genomic DNA Purification kit (Promega, Madison, WI); DNA purity and concentration were determined by measuring the 260 to 280 nm and 260 to 230 nm absorbance ratios using a GeneQuant UV spectrophotometer (GE Healthcare Life Sciences, Piscataway, NJ). Porcine and ovine SCD promoters were amplified from genomic DNA by PCR using highfidelity Amplitaq Gold (Applied Biosystems, Foster City, CA) and the primers listed in Table 1 . Polymerase chain reaction primers spanning the promoter region for porcine SCD were designed based on the available sequence (AY487830), but the ovine SCD promoter sequence was not available. Therefore, primers for ovine SCD were designed based on the alignment of the SCD promoters for 4 different species: cow (AY241932), pig (AY487830), human (AF320307), and mouse (MSDS1). All PCR products were sequenced before progressing.
Nested PCR was then used to produce both fulllength promoter constructs and shorter constructs (Figure 1 ) lacking the postulated PUFA-RR. The primers (Table 2) were designed with different restriction sites (Mlu I and BglII) at the 2 ends to allow cloning of the constructs into the pGL3 basic vector (Promega) in the correct orientation, using T4 DNA ligase and buffer (Invitrogen, Carlsbad, CA) according to the instructions of the manufacturer. Similar constructs containing the human and mouse SCD promoters ( Figure  1 ) were also obtained (from J. Ntambi, University of Wisconsin-Madison) and all constructs were sequenced to confirm promoter insertion and orientation. The constructs were all transformed into competent JM109 Escherichia coli and grown and amplified in Luria-Bertani media [10 g/L of Bacto tryptone, 5 g/L of Bacto yeast extract (Oxoid Ltd., Basingstoke, Hampshire, UK) 10 g/L of NaCl in distilled water, autoclaved before use] containing ampicillin, before isolating the vectors using a GenElute Endotoxin-Free Midiprep system (SigmaAldrich, St. Louis, MO) for cell transfection studies. serum, penicillin, and streptomycin (all from SigmaAldrich)] at 37°C in a humidified incubator with 5 or 10% CO 2 , respectively. Before transfection, all cells were growing in the log phase, having been plated and allowed to reach 50 to 80% confluence. Cells were transiently transfected with luciferase reporter vectors using Fugene 6 transfection reagent (Roche, Basel, Switzerland). Briefly, the growth medium was replaced with transfection medium (without antibiotics). The same amount of DNA (1 µg) was always used in transfections by making up any differences with salmon testes DNA. The Fugene 6-DNA complex was prepared and added to cells, as described by the protocol of the manufacturer, at the optimal ratio of Fugene to DNA of 3:1 (data not included). The DNA was made up of 0.5 µg of pGL3 basic constructs containing the species-specific SCD promoters; 0.1 µg of pRL Renilla luciferase construct (Promega); 10 ng of a truncated nuclear (active) form of human SREBP1c (nSREBP1c) overexpression vector (when applicable), and salmon testes DNA, with pGL3 basic and pGL3 control constructs (Promega) used as negative and positive controls, respectively, to check for successful transfection. After 24 h of transfection, the medium was changed to normal growth medium (Dulbecco's modified Eagle's medium containing 8% fetal calf serum and antibiotics) containing the control, fatty acid, or sterol treatments. Cell culture grade oleic and linoleic acids bound to albumin (100 mg/mL of BSA, Sigma-Aldrich) were diluted in growth medium to a concentration of 60 µM. Control cells were treated with fatty acid-free BSA alone in growth medium. A mixture of cholesterol (10 µg/mL) and 25-hydroxycholesterol (1 µg/mL) was added to cells as the sterol treatment, with the same amount of ethanol (used as a vehicle for sterol) being used as the control (0.1% vol/vol). Treatments were added for 24 h before measurement of SCD promoter activities via luciferase assays or gene expression via real-time PCR.
Cell Culture and Transfection

Luciferase Assay and Quantitative Real-Time PCR
Firefly and Renilla luciferase activities were measured (according to the instructions of the manufacturer) using the Dual Luciferase Assay kit (Promega) and a luminescence plate reader with automatic injection (BMG Labtech, Offenburg, Germany).
Where applicable, total RNA was isolated from control and treated cells using Trizol (Invitrogen), before cDNA was synthesized using random hexamers and Moloney murine leukemia virus reverse transcriptase and buffer (Promega). Gene and species specific primers and probes for real-time PCR (Table 2) were purchased from Applied Biosystems [glyceraldehyde 3-phosphate dehydrogenase (GAPDH)] or were designed using PrimerExpress (Applied Biosystems) and purchased from Sigma-Aldrich. Gene expression was quantified via the standard curve method on the Lightcycler 480 Roche diagnostic system using 384-well plates and reverse transcription-PCR Mastermix (Roche). Because of species-specificity of available primers and probes, different control genes had to be used for the 2 cell lines, with human GAPDH and rat β-actin being used for HEK 293 and McA-RH7777 cells, respectively.
Statistical Analyses
Because cell lines were used, 3 or 4 biological replicates (i.e., culture wells) were sufficient for each treatment, with luciferase assays performed in triplicate for each sample (well) and with the mean used in statistical analyses. Luciferase and mRNA expression data relative to unstimulated controls are expressed as means (n = 3 or 4) and SEM. All data were analyzed by 1-, 2-, or 3-way ANOVA using GenStat (VSN International Ltd., Hemel Hempstead, UK). A post hoc Dunnett's test was used to identify differences between the control and treatment groups, but only when no interactions were observed. Statistical significance was taken as P < 0.05.
RESULTS
Comparison of SCD Promoter Sequences Across Species
Alignment of sequences generated for ovine and porcine SCD promoter regions with the published mouse SCD1 (accession number MSDS1) and human SCD (accession number AF320307) promoters demonstrated that the postulated PUFA-RR was highly conserved across species (Figure 2) . The novel ovine SCD promoter region (716 bp upstream from the open reading frame) shared 76% sequence similarity with human SCD and 67% with mouse SCD1. The similarities were even greater when compared with published porcine and bovine SCD promoter sequences, being 92 and 94% similar, respectively. Zhang et al. (2001) identified human SCD transcription start sites at −194 and −145, whereas Waters et al. (1997) mapped the transcription start site for mouse SCD1 at −153 and Ren et al. (2004) confirmed the porcine SCD transcription start site at −172 (highlighted in gray in Figure 2) . Alignment of the isolated porcine SCD promoter with that previously reported (accession number AY487830) showed that they were 99% identical. We suggest, based on the published work for mouse SCD1, human SCD, and porcine SCD and alignment of the 4 species, that the region from −164 to −148 for ovine SCD is likely to contain the transcription start site. Note that human GAPDH was measured using an Applied Biosystems kit (product code Hs00266705_g1, Applied Biosystems, Foster City, CA).
The Effects of Fatty
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content/vol88/issue8) and McA-RH7777 cells (Supplemental Figure 2 ) after a 24-h treatment. For subsequent studies, 60 µM was chosen because this was thought to minimize the chance of toxicity. To compare the effects of fatty acids on the mouse, human, porcine, and ovine SCD promoter activities, SCD promoter constructs were transfected into either HEK 293 or McA-RH7777 cells and incubated with 60 µM oleic or linoleic acid for 24 h or with BSA alone as the control. Linoleic acid significantly downregulated (P < 0.05; Figures 3 and 4) all SCD promoters containing the PU-FA-RR (mouse SCD, human SCD, porcine ASCD, and ovine ASCD) in both cell types, with the exception of the human SCD promoter in HEK 293 cells (P = 0.093; Figure 3 ). Oleic acid tended to show similar effects, downregulating all SCD promoters containing the PU-FA-RR (P < 0.05; Figures 3 and 4) , except human SCD in HEK 293 cells and porcine ASCD in McA-RH7777 cells. As expected, there were no effects of either fatty acid on the porcine and ovine SCD promoter constructs lacking the PUFA-RR [porcine BSCD and ovine BSCD (with B indicating a construct lacking the PUFA response region); P < 0.01 for treatment × construct interactions].
The Effects of Oleic and Linoleic Acids on Endogenous SCD mRNA Expression
Because differences had been expected between the 2 cell lines in terms of responses of the different species SCD promoters to fatty acids, the effects of the 2 fatty acids on endogenous expression of SCD1 in the 2 cell lines was measured. Neither oleic acid nor linoleic acid had any effect on human GAPDH and rat β-actin, the control genes used for HEK 293 and McA-RH7777 cells, respectively (data not shown).
There were effects of fatty acid treatment on human SCD and rat SCD1 mRNA expression in HEK 293 (P < 0.001) and McA-RH7777 (P = 0.002) cells, respectively ( Figure 5 ). Endogenous SCD mRNA gene expression was downregulated by both oleic and linoleic acids in both cell types, with linoleic acid being more potent.
The Effects of Sterol and SREBP Overexpression on Mouse, Human, Porcine, and Ovine SCD Promoter Activities
The PUFA-RR contains a SRE that may play a role in the observed regulatory effects of fatty acids. Sterol regulatory element binding proteins are transcription factors that bind to this SRE region and stimulate gene transcription, and they may be involved in the effects of fatty acids (Tabor et al., 1999) . Therefore, the effect of overexpressing nSREBP1c on SCD promoter activities of different species was investigated. Preliminary studies indicated dose-dependent increases in human and mouse SCD promoter activities after transfection with up to 10 ng of nSREBP1c construct in HEK 293 cells, but transfection with greater amounts (25, 250, and 500 ng) resulted in a relative reduction in human SCD promoter activity (Supplemental Figure 3; http://jas. fass.org/content/vol88/issue8). Hence, there appears to be a bell-shaped response curve, so the amount resulting in the maximum response (10 ng) was used for subsequent studies. Hua et al. (1996) showed that the production of nSREBP1c is downregulated by treatment with cholesterol or sterol; therefore, the effect of sterol on SCD promoter activities was also investigated in a 2 × 2 factorial arrangement of treatments.
There was no difference among species in SCD promoter constructs containing the PUFA-RR in their responses to sterol or nSREBP1c in HEK 293 cells ( Figure 6 ). Sterol had no effect on any SCD promoter activities, whereas nSREBP1c dramatically upregulated all SCD promoter activities (P < 0.001 for SREBP effects), except those lacking the PUFA-RR (porcine BSCD and ovine BSCD, P < 0.001 for both SREBP × construct interactions). The combination of sterol and nSREBP1c together resulted in no effect compared with nSREBP1c alone, indicating that sterol was unable to alter the effects of overexpressing nSREBP1c in HEK 293 cells.
In contrast, very different responses to SREBP and sterol were observed in McA-RH7777 cells (Figure 7) , with significant interactions between SREBP, sterol, and construct observed. Sterol reduced (P < 0.001 for human and mouse constructs) SCD promoter activity for each of the species studied when constructs contained the PUFA-RR, but had no effect on the porcine and ovine SCD constructs lacking the PUFA-RR (P < 0.001 for both sterol × construct interactions). Overexpression of nSREBP1c upregulated mouse and human SCD promoter activities (P ≤ 0.001), but had no effect on ovine ASCD and seemed to downregulate porcine ASCD promoter activity. An interaction between SREBP and sterol was observed for human SCD (P = 0.024), but not mouse SCD (P = 0.152); interactions between construct, SREBP, and sterol were observed for porcine (P < 0.001) and ovine (P = 0.017) SCD promoter activities. Hence, nSREBP1c overexpression tended to block the sterol-induced downregulation of human, porcine, and ovine (but not mouse) SCD promoters, but only when the PUFA-RR was present.
Generally, the upregulation of SCD promoter activities by nSREBP1c was greater in HEK 293 cells compared with McA-RH7777 cells, whereas the downregulation of SCD promoter activities by sterol was greater in McA-RH7777 cells compared with HEK 293 cells. This may relate to differences in endogenous SREBP expression between the 2 cell lines. Furthermore, the position on the bell-shaped dose-response curve for nSREBP1c overexpression will also depend on the endogenous expression of SREBP1c, and may account for the apparent downregulation of the porcine SCD promoter containing the PUFA-RR (pASCD) in McA-RH7777 cells but an upregulation in HEK 293 cells. Interestingly, the mouse SCD1 promoter appeared to be more responsive to nSREBP1c overexpression than the other SCD promoters. The reason for this is unclear, although the PUFA-RR in the mouse SCD1 promoter contains 3 base differences compared with the other species (Figure 2 ).
DISCUSSION
Alignment of the novel promoter region of ovine SCD-1 with that of other species showed the expected high homology between ovine and bovine sequences, but also a similar amount of homology with the porcine sequence. Although homology between these farm animal species and the mouse and human was less, it was of note that, in all species, the putative PUFA-RR was highly conserved. This region was originally shown to be important for the response of the mouse SCD-1 promoter to both fatty acids and sterols (Tabor et al., 1999) . It contains several potential transcription factor binding sites, including a perfectly conserved region identified as an SRE. Truncation of the ovine and porcine promoters to exclude the PUFA-RR markedly reduced activity, particularly in the McA-RH7777 hepatoma cells. This indicates transcription factor binding to this region is important in maintaining SCD-1 expression in the liver.
One of the aims of this study was to investigate whether differences in promoter structure might be responsible for reported differences in responsiveness to Figure 2 . Alignment of ovine, bovine, porcine, human, and murine stearoyl CoA desaturase promoter sequences using ClustalW (http://www. ebi.ac.uk/Tools/clustalw2/index.html). The gray area containing specificity protein 1 (Sp1), sterol response element (SRE), and nuclear factor (NF)-Y/NF-1 binding sites is the postulated PUFA response region; the smaller gray boxes indicate published transcription start sites for the different species. The mouse, human, and porcine sequences are from the database, whereas the ovine sequence was generated during these studies. An asterisk (*) indicates agreement across all sequences. fatty acids among species. Of particular interest was the apparent difference in responsiveness of the bovine SCD promoter that, in MacT (bovine mammary epithelial) cells, failed to respond to linoleic acid but was downregulated by oleic acid (Keating et al., 2006) . In fact, the effect of fatty acids on promoter activity was remarkably consistent for the 4 species studied. Both oleic and linoleic acid reduced promoter activities. Thus, the differences observed previously are likely due to differences in the amounts and combinations of transcription factors present in the different cell types studied. For example, the current data show that the reduction of SCD promoter activity in response to linoleic acid in McA-RH7777 cells (60 to 80%) was considerably greater than that in HEK 293 cells (30 to 40%) for each of the 4 SCD promoter constructs studied, indicating that the response to a particular factor may vary with tissue or cell type.
It has been recognized for many years that diets rich in unsaturated fatty acids suppress SCD activity in rodents (Jeffcoat and James, 1978) . Landschulz et al. (1994) demonstrated, in primary cultures of rat hepatocytes, that the potency of unsaturated fatty acids increased with the number of double bonds. Thus, oleic acid reduced mRNA concentrations by approximately 25%, linoleic acid by 50%, and arachidonic acid by almost 90%. This is in keeping with our finding of the effects of oleic and linoleic acids on promoter activities Figure 2 (Continued). Alignment of ovine, bovine, porcine, human, and murine stearoyl CoA desaturase promoter sequences using ClustalW (http://www.ebi.ac.uk/Tools/clustalw2/index.html). The gray area containing specificity protein 1 (Sp1), sterol response element (SRE), and nuclear factor (NF)-Y/NF-1 binding sites is the postulated PUFA response region; the smaller gray boxes indicate published transcription start sites for the different species. The mouse, human, and porcine sequences are from the database, whereas the ovine sequence was generated during these studies. An asterisk (*) indicates agreement across all sequences. Significant effects of fatty acids were observed for mASCD (P < 0.001) and hASCD (P < 0.001), and significant interactions between the SCD promoter construct and fatty acids were observed for pig (P < 0.001) and sheep (P < 0.001). **P < 0.01 difference relative to the control (Dunnett's test). A significant effect of fatty acids was observed for mASCD (P = 0.009), and a similar trend was observed for hASCD (P = 0.093). A significant interaction between the SCD promoter construct and fatty acids was observed for pig (P < 0.001) and a similar trend was observed for sheep (P = 0.059). *P < 0.05, **P < 0.01 difference relative to the control (Dunnett's test).
in McA-RH7777 cells. Waters et al. (1997) were the first to identify a homologous region of the mouse SCD-1 and SCD-2 promoters responsible for regulation by fatty acids and designated it the PUFA-RR. The current study confirms that this region is essential in conferring sensitivity to fatty acids in both the ovine and porcine SCD promoters. We also demonstrated that the SRE within this region is active because cotransfection Figure 5 . The effects of oleic and linoleic acids on endogenous expression of human (hSCD1) and rat (rSCD1) stearoyl CoA desaturase (SCD) mRNA [corrected using human glyceraldehyde 3-phosphate dehydrogenase (GAPDH) or rat β-actin mRNA] in HEK 293 and McA-RH7777 cells, respectively. Significant effects of fatty acids were observed for hSCD1 (P < 0.001) and rSCD1 (P = 0.002) mRNA expression. *P < 0.05, **P < 0.01 difference relative to the control (Dunnett's test). Figure 6 . The effects of sterol and nuclear human sterol regulatory element binding protein (SREBP)-1c (nSREBP1c) overexpression on mouse (mASCD), porcine (pASCD and pBSCD), human (hASCD), and ovine (oASCD and oBSCD) stearoyl CoA desaturase (SCD) promoter activities in HEK 293 cells. The A and B indicate constructs containing (A) or lacking (B) the PUFA response region. A significant effect of SREBP was observed for mASCD (P < 0.001), but no effect of sterol was observed. A SREBP × sterol interaction was observed for hASCD (P = 0.051) and significant SCD promoter construct × SREBP interactions (P < 0.001) were observed for pig and sheep, but there were no effects of sterol on pig and sheep SCD promoter activities. **P < 0.01 difference relative to the control (Dunnett's test).
of HEK 293 cells with a human nSREBP1c construct leads to a dramatic increase in promoter activity. Furthermore, in the liver-derived McA-RH7777 cells (in which endogenous SREBP expression is high), a combination of cholesterol and 25-hydroxycholesterol markedly reduced activity of all the promoters studied. It is well established that sterols inhibit the posttranslational maturation of SREBP by preventing the processing and release from the endoplasmic reticulum (Hua et al., 1996) . It has also been postulated that this SRE is responsible for the fatty acid responsiveness of SCD (Ntambi, 1999) . Polyunsaturated fatty acids have been shown to inhibit SREBP1c transcription by reducing the activity of the liver X receptor, a transcription factor known to stimulate SREBP1c expression (Yoshikawa et al., 2002) . Whether oleic acid also works via SREBP expression or activity, or another mechanism, requires further investigation. However, other mechanisms by which fatty acids (including oleic acid) regulate SCD expression probably exist in both lipogenic and nonlipogenic tissues.
In conclusion, in this study we isolated and partially characterized the novel promoter region for the ovine SCD gene. We showed a high degree of homology between the ovine, bovine, and porcine SCD promoters and showed that the PUFA-RR, originally identified in mice, was perfectly conserved in all 3 species. Using promoter or reporter gene constructs, we showed that the ovine, porcine, mouse, and human SCD promoters responded similarly to unsaturated fatty acids and that the PUFA-RR is required to elicit such responses. In each species, this region contains an active SRE. Thus, species differences previously reported in the regulation of SCD expression by fatty acids 1) were not observed and 2) are not due to differences in promoter structure, but may be dependent on the cell type used or the relative concentrations and distribution of SREBP or other transcription factors. Figure 7 . The effects of sterol and nuclear sterol regulatory element binding protein (SREBP)-1c (nSREBP1c) overexpression on mouse (mASCD), porcine (pASCD and pBSCD), human (hASCD), and ovine (oASCD and oBSCD) stearoyl CoA desaturase (SCD) promoter activities in McA-RH7777 cells. The A and B indicate constructs containing (A) or lacking (B) the PUFA response region. Significant effects of SREBP (P < 0.001) and sterol (P < 0.001) were observed for mASCD, but no interaction. A significant SREBP × sterol interaction was observed for hASCD (P = 0.024) and significant SCD promoter construct × SREBP × sterol interactions were observed for pig (P < 0.001) and sheep (P = 0.017). **P < 0.01 difference relative to the control (Dunnett's test).
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